Janssen Saskia, Wieten Rosanne Willemijn, Stolp Sebastiaan, Cremers Anne Lia, Rossatanga Elie Gide, Klipstein-Grobusch Kerstin, Belard Sabine, Grobusch Martin Peter
Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands; Centre de Traitement Ambulatoire, Lambaréné, Gabon; Centre de Recherches Médicales de Lambaréné (CERMEL), Lambaréné, Gabon; Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany; Clinical Infectious Diseases Research Initiative, Institute for Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Center of Tropical Medicine and Travel Medicine, Department of Infectious Diseases, Division of Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
PLoS One. 2015 Oct 16;10(10):e0140746. doi: 10.1371/journal.pone.0140746. eCollection 2015.
Retention to HIV care is vital for patients' survival, to prevent onward transmission and emergence of drug resistance. Travelling to receive care might influence adherence. Data on the functioning of and retention to HIV care in the Central African region are limited.
This retrospective study reports outcomes and factors associated with retention to HIV care at a primary HIV clinic in Lambaréné, Gabon. Adult patients who presented to this clinic between January 2010 and January 2012 were included. Outcomes were retention in care (defined as documented show-up for clinical visits, regardless of delay) or LTFU (defined as a patient not retained in care; on ART or ART naïve, not returning to care during the study period with a patient delay for scheduled visits of more than 6 months), and mortality. Cox regression analysis was used to assess factors associated with respective outcomes. Qualitative data on reasons for LTFU were obtained from focus-group discussions.
Of 223 patients included, 67.3% were female. The mean age was 40.5 (standard deviation 11.4) years and the median CD4 count 275 (interquartile range 100.5-449.5) cells/μL. In total, 34.1% were lost to follow up and 8.1% died. Documented tuberculosis was associated with increased risk of being LTFU (adjusted hazard ratio (aHR) 1.80, 95% confidence interval (95% CI) 1.05-3.11, P = 0.03), whereas early starting anti-retroviral therapy (ART) was associated with a decreased risk of LTFU (aHR 0.43, 95%CI 0.24-0.76, P = 0.004), as was confirmed by qualitative data.
Retention to HIV care in a primary clinic in Gabon is relatively poor and interventions to address this should be prioritized in the HIV program. Early initiation of ART might improve retention in care.
持续接受艾滋病治疗对于患者生存、预防病毒传播及耐药性出现至关重要。前往接受治疗可能会影响依从性。中非地区艾滋病治疗机构的运行情况及患者持续治疗情况的数据有限。
这项回顾性研究报告了加蓬兰巴雷内一家初级艾滋病诊所中与持续接受艾滋病治疗相关的结果及因素。纳入了2010年1月至2012年1月期间到该诊所就诊的成年患者。结果指标为持续接受治疗(定义为有记录显示前来进行临床就诊,无论是否延迟)或失访(定义为未持续接受治疗的患者;无论是否接受抗逆转录病毒治疗,在研究期间未返回治疗且患者延迟预定就诊时间超过6个月),以及死亡率。采用Cox回归分析评估与各结果相关的因素。通过焦点小组讨论获取了关于失访原因的定性数据。
纳入的223名患者中,67.3%为女性。平均年龄为40.5(标准差11.4)岁,CD4细胞计数中位数为275(四分位间距100.5 - 449.5)个/μL。共有34.1%的患者失访,8.1%的患者死亡。有记录的结核病与失访风险增加相关(调整后风险比[aHR]为1.80,95%置信区间[95%CI]为1.05 - 3.11,P = 0.03),而定性数据证实,早期开始抗逆转录病毒治疗(ART)与失访风险降低相关(aHR为0.43,95%CI为0.24 - 0.76,P = 0.004)。
加蓬一家初级诊所的艾滋病治疗持续情况相对较差,艾滋病项目应优先采取干预措施解决这一问题。早期启动抗逆转录病毒治疗可能会改善治疗持续情况。